InVivo Therapeutics is a research and clinical-stage biotechnology company focused on the development of technologies for the treatment of spinal cord injuries (SCIs). InVivo’s mission is to ...

AbbVie, and others. DelveInsight's Spinal Cord Injury Market Insights report includes a comprehensive understanding of current treatment practices, spinal cord injury emerging drugs, market share ...

Grégoire Courtine and Jocelyne Bloch at the Christopher & Dana Reeve Foundation gala in 2022. (Bryan Bedder ... careers trying to find treatments for spinal cord injury. Bloch has long been ...

Nov. 29, 2022 — Unique new material has shown significant promise in the treatment of spinal cord injury. The new hybrid biomaterials, in the form of nanoparticles and building on existing ...

At Harborview Medical Center in Seattle, an FDA-approved therapy for spinal cord injuries is offering new hope to patients like Jessie Owen. Owen, who was paralyzed in a tragic accident over a ...

The US Food and Drug Administration (FDA) has granted de novo classification to Onward Medical for its ARC-EX system in patients with spinal cord injury ... up from $6bn in 2022.